Infectious Diseases Related News
US researchers collaborate to combat deadly Clostridium difficile superbug
A team of US biologists have conducted a novel study to attain unprecedented insights into Clostridium difficile, an incredibly virulent superbug that’s claims thousands...
First long-acting injectable HIV treatment approved by NICE
The National Institute for Health and Care Excellence (NICE) has approved a new HIV treatment that can be injected rather than taken orally in a...
Allergies linked to low COVID-19 infection risk
A new study published in the respiratory journal Thorax, found that individuals with allergies such as hay fever, rhinitis, and atopic eczema, may have...
First new covid variant cases found in UK
Following overnight genome sequencing, the UK Health Security Agency (UKHSA) has confirmed three cases of the new covid variant, Omicron (B.1.1.529), in the UK...
Omicron named a SARS-CoV-2 variant of concern by WHO
The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE), independent experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assess mutations and...
Risk of COVID-19 infection steadily increases after second vaccine dose
A research team based in Israel has identified that the risk of infection from COVID-19 gradually increases after receiving a second vaccine dose.
Research emerging...
COVID-19 demonstrates the ability to infect an unborn baby
Researchers have identified that an unborn baby can potentially contract COVID-19 infection, uncovering the mechanism behind catching the virus.
A study, led by researchers from...
Combatting Crimean-Congo haemorrhagic fever with COVID technology
A scientific research consortium called Prometheus is employing the same framework used to develop COVID-19 vaccines to tackle Crimean-Congo haemorrhagic fever.
Crimean-Congo haemorrhagic fever (CCHF)...
SSRI antidepressants observed to protect COVID-19 patients from death
Novel research from the US has identified that SSRI antidepressants may possess qualities that help to reduce deaths in COVID-19 patients.
In a study conducted...
Investigating the impacts of COVID-19 variants on dialysis treatment
A team of international researchers has examined the efficacy of COVID-19 vaccines for patients undergoing dialysis treatment.
The study, led by experts at the Marien...
Ebola vaccine by University of Oxford to begin human trials
The University of Oxford has begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers against Zaire and Sudan...
Defence Therapeutics: Optimising drug efficacy with AccumTM technology
Health Europa is excited to introduce the latest captivating eBook from industry pioneers of the biotechnology sector, Defence Therapeutics, who comprehensively elucidate their revolutionary...
Licensing agreed by University of Birmingham for COVID nasal spray
The University of Birmingham has signed a licensing agreement with Birmingham Biotech Ltd to commercialise an anti-viral COVID nasal spray that can offer protection...
Gene discovered in humans linked to doubling the risk of COVID deaths
Radcliffe Department of Medicine at the University of Oxford have identified the gene responsible for doubling the risk of COVID deaths.
Scientists at the University...
Pfizer/BioNTech booster vaccine reduces COVID-19 hospitalisations
In the most extensive real-world study to date, an international research team has identified that the Pfizer/BioNTech booster vaccine is highly effective at reducing...
Sniffing out COVID-19 with medical detection dogs
Claire Guest, Co-Founder, CEO and Chief Scientific Officer of Medical Detection Dogs, outlines how the charity is training dogs to detect COVID-19.
Medical Detection Dogs...
Fluvoxamine medication lowers risk of hospitalisation from COVID-19
In the largest randomised clinical trial to date, researchers have demonstrated that the drug fluvoxamine is proficient at reducing the risk of prolonged hospitalisation...
Uncovering why the COVID-19 Delta Variant is exceptionally infectious
Research emerging from the United States has revealed what makes the dreaded COVID-19 Delta Variant so infectious, a breakthrough that may help to design...
COVID-19 antibodies significantly boosted in double vaccinated individuals
A study conducted in Sweden has elucidated that although COVID-19 antibodies are reduced in the airways following SARS-CoV-2 infection, two vaccine doses increase these...
Forecasting COVID-19 hospitalisations and deaths with cell discovery
A team of scientists has made a novel cell discovery that may be able to predict the probability of COVID-19 hospitalisations and deaths.
The University...